Core benefits: accuracy, reproducibility, scalability
CSEM’s lab automation goes far beyond simple pipetting robots. By combining microfluidics, precision liquid handling, intelligent cell and biomaterial handling, advanced sensors, imaging, and real-time data analytics, we build complete smart labs and lab-on-a-chip systems.
Our solutions accelerate diagnostics, drug development, and regenerative medicine by automating complex processes with minimal human intervention. This approach delivers consistent, high-throughput results, reduces manual error, and enables the seamless scaling of laboratory workflows from research to industrial production.
CSEM brings unmatched breadth of expertise to laboratory automation. By combining engineering and life sciences under one roof, we deliver solutions that are robust, scalable, and ready for the most demanding applications.
CSEM designs, develops, and tests innovative microfluidic and automation systems that precisely manipulate fluids, single cells, organoids, and complex biomaterials.
Our integrated expertise covers microfluidics, precision liquid handling, and intelligent biological sorting, enabling custom solutions that boost research accuracy, throughput, and reproducibility.
At CSEM, innovation in lab automation is a collaborative journey. We work closely with industry leaders and research partners to co-design systems that address real-world laboratory challenges.
By combining your domain expertise with our engineering and automation know-how, we deliver solutions that accelerate time-to-market and integrate seamlessly into your workflows.
La collaboration avec le CSEM a permis de développer et d’améliorer considérablement notre système VeriPlate. Grâce à son expertise en microfluidique, nous avons atteint un niveau de précision et de fiabilité inédit, et établi une nouvelle norme en matière d’automatisation des laboratoires. Ce partenariat a joué un rôle déterminant dans l’amélioration des performances de notre produit et dans son succès commercial.
We aim to provide a platform technology that facilitates a seamless transition from small-scale preclinical testing to large-scale manufacturing following approval. It will enable healthcare providers to safely produce more cell and gene therapy treatment doses per square meter of cleanroom facility.
L’expertise du CSEM s’est avérée essentielle pour le développement d’une nouvelle technologie de bio-impression, capable d’imprimer de multiples matériaux. Leur précieux soutien en microfluidique a conduit à des avancées significatives. Le codéveloppement du module de formulation dynamiquenous a permis d’enrichir notre portefeuille de produits et renforcer notre position sur le marché.
DeckCheck renforcera la plate-forme Fluent de Tecan en fournissant une assistance de pointe pour la configuration et la vérification des flux de production. Cette approche réduira considérablement les erreurs d’utilisation, lesquelles sont à l’origine d’une proportion considérables d’incidents de flux de production. Cela contribuera à réduire fortement les pertes d’échantillons et de consommables, et donc les baisses de rendement.
Multi-axis mechanical stimulation supports realistic preclinical testing of disc implants and regenerative therapies.
Controlled bioreactor environment promotes growth of implantable, patient-specific cardiovascular tissues.
Breakthrough microfluidic system sorts millions of cells per second for advanced biomedical research and therapy manufacturing.
Closed, automated system expands and modifies cells efficiently, shortening CAR-T therapy timelines.
Lab-on-a-chip platform rapidly screens drug candidates, combining precise microfluidic control with automated analysis for accelerated pharmaceutical development.
Ultra-fast microfluidic technology enables single-cell analysis to identify effective, patient-specific therapies.
Innovative microfluidic chips accelerate pharmaceutical R&D with precise fluid manipulation and scalable processes.
Compact microfluidic system lowers RNA sequencing costs and boosts throughput, making genomic analysis broadly accessible.
Patient-derived cells are tested on microfluidic chips to rapidly identify the most effective cancer treatment.
A world-first sensor developed by Fluigent and CSEM measures microfluidic flow accurately without disturbing delicate samples.
Optical detection ensures every micro-drop is accurately dispensed, improving reliability in automated liquid handling.
Validates pipetting precision across microplates, safeguarding reproducibility in automated laboratories.
Detects labware misplacements in 1.5 seconds, reducing human error and ensuring reliable workflows.
Join pharma and biotech leaders already enhancing their R&D with CSEM's cutting-edge lab automation solutions. Discuss your automation needs with our experts and explore how CSEM can accelerate your research breakthroughs.